Volume 138, Issue 2

Search all Acta Neuropathologica articles

August 2019

Alzheimer's disease risk genes: a close-up view (Pages: 171 - 236)

Issue Editor:

Kristel Sleegers

13 articles in this issue

Novel Alzheimer’s disease risk genes: exhaustive investigation is paramount
Kristel Sleegers
Christine Van Broeckhoven
Editorial 12 July 2019 Pages: 171 - 172
SORL1 genetic variants and Alzheimer disease risk: a literature review and meta-analysis of sequencing data
Dominique Campion
Camille Charbonnier
Gaël Nicolas
Review 25 March 2019 Pages: 173 - 186
Evaluation of CD33 as a genetic risk factor for Alzheimer’s disease
Steven Estus
Benjamin C. Shaw
David W. Fardo
Review 04 April 2019 Pages: 187 - 199
The role of ABCA7 in Alzheimer’s disease: evidence from genomics, transcriptomics and methylomics
Arne De Roeck
Christine Van Broeckhoven
Kristel Sleegers
Review Open access 22 March 2019 Pages: 201 - 220
The new genetic landscape of Alzheimer’s disease: from amyloid cascade to genetically driven synaptic failure hypothesis?
Pierre Dourlen
Devrim Kilinc
Jean-Charles Lambert
Review Open access 13 April 2019 Pages: 221 - 236
A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity
Sven J. van der Lee
Olivia J. Conway
Henne Holstege
Original Paper Open access 26 May 2019 Pages: 237 - 250
Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer’s disease
Antonio Boza-Serrano
Rocío Ruiz
Tomas Deierborg
Original Paper Open access 20 April 2019 Pages: 251 - 273
RhoA regulates translation of the Nogo-A decoy SPARC in white matter-invading glioblastomas
Peter Wirthschaft
Julia Bode
Björn Tews
Original Paper Open access 06 May 2019 Pages: 275 - 293
Mutational patterns and regulatory networks in epigenetic subgroups of meningioma
Nagarajan Paramasivam
Daniel Hübschmann
Felix Sahm
Original Paper 08 May 2019 Pages: 295 - 308
Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypes
Tanvi Sharma
Edward C. Schwalbe
Steven C. Clifford
Original Paper Open access 10 May 2019 Pages: 309 - 326
Molecular progression of SHH-activated medulloblastomas
Andrey Korshunov
Konstantin Okonechnikov
Marcel Kool
Correspondence 27 April 2019 Pages: 327 - 330
Lack of H3K27 trimethylation is associated with 1p/19q codeletion in diffuse gliomas
Katharina Filipski
Yannick Braun
Patrick N. Harter
Correspondence Open access 07 May 2019 Pages: 331 - 334
ALK-positive histiocytosis with KIF5B-ALK fusion in the central nervous system
Calixto-Hope G. Lucas
Ahmed Gilani
Arie Perry
Correspondence 22 May 2019 Pages: 335 - 337

Volume 138, Issue 2

Novel Alzheimer’s disease risk genes: exhaustive investigation is paramount

SORL1 genetic variants and Alzheimer disease risk: a literature review and meta-analysis of sequencing data

Evaluation of CD33 as a genetic risk factor for Alzheimer’s disease

The role of ABCA7 in Alzheimer’s disease: evidence from genomics, transcriptomics and methylomics

The new genetic landscape of Alzheimer’s disease: from amyloid cascade to genetically driven synaptic failure hypothesis?

A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity

Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer’s disease

RhoA regulates translation of the Nogo-A decoy SPARC in white matter-invading glioblastomas

Mutational patterns and regulatory networks in epigenetic subgroups of meningioma

Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypes

Molecular progression of SHH-activated medulloblastomas

Lack of H3K27 trimethylation is associated with 1p/19q codeletion in diffuse gliomas

ALK-positive histiocytosis with KIF5B-ALK fusion in the central nervous system

Navigation